Evaluation of an anti-inflammatory factor derived from hyperimmunized cows.

Area of Science:

• Immunology
• Veterinary Science
• Biochemistry

Background:

• Bovine milk contains bioactive compounds with potential therapeutic properties.
• Mastitis, a significant economic issue in dairy farming, is caused by Staphylococcus aureus infections.
• The non-specific immune system plays a crucial role in combating bacterial infections like mastitis.

Purpose of the Study:

• To investigate the in vitro and in vivo effects of a novel anti-inflammatory factor isolated from hyperimmunized cow's milk.
• To determine the factor's impact on macrophage phagocytosis and host resistance against Staphylococcus aureus.
• To evaluate the factor's efficacy in mitigating mammary inflammation and improving immune response.

Main Methods:

• In vitro analysis of macrophage phagocytic activity against Staphylococcus aureus.
• In vivo studies using a mouse model with intraperitoneal and intramammary Staphylococcus aureus challenge.
• Assessment of host survival (LD50), mammary gland histology, and bacterial load.
• Quantitative histologic analysis of mammary tissues.

Main Results:

• The anti-inflammatory factor enhanced macrophage phagocytosis of Staphylococcus aureus in vitro.
• Mice treated with the factor showed increased LD50 and reduced mammary inflammation and involution post-challenge.
• Histologic analysis revealed improved mammary gland structure and reduced leukocyte infiltration in treated mice.
• Fewer colony-forming units of Staphylococcus aureus were observed in mammary glands of treated mice.

Conclusions:

• The isolated anti-inflammatory factor demonstrates potent immunomodulatory effects.
• It enhances the non-specific defense system, improving resistance to Staphylococcus aureus infections.
• This factor holds promise for therapeutic applications in combating mastitis and other inflammatory conditions.